Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strat...
Q3 2026
May 14, 2026
Q2 2026
Feb 17, 2026
Q1 2026
Nov 14, 2025
FY 2025
Sep 26, 2025
Q4 2025